Interleukin-10 -1082 promoter polymorphism associated with gastric cancer among Asians

European Journal of Cancer

Volumn 44, Issue 17, 2008, Pages 2648-2654

  Zhou, Yong ^a   Li, Ni ^a   Zhuang, Wen ^a   Liu, Guan Jian ^b   Wu, Tai Xiang ^b   Yao, Xun ^b   Du, Liang ^b   Wei, Mao Ling ^b   Wu, Xiao Ting ^a  

^a SICHUAN UNIVERSITY   (China)

^b Chinese Evidence Based Medicine/Cochrane Center   (China)

Author keywords

Gastric cancer; Gene polymorphism; Interleukin 10; Meta analysis

Indexed keywords

INTERLEUKIN 10;

ARTICLE; ASIAN; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; EMBASE; EVIDENCE BASED PRACTICE; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDLINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE STUDY; RACE; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; STOMACH CANCER; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; HUMANS; INTERLEUKIN-10; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 55249123107     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.07.017     Document Type: Article

References (42)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Boyle P. Favorable trends in cancer mortality in the European Union but no room for complacency. Ann Oncol 19 (2008) 605-606
3. Gondos A., Bray F., Brewster D.H., et al. Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 44 (2008) 1463-1475
4. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 (2008) 1345-1389
5. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
6. Devesa S.S., and Fraumeni Jr. J.F. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 91 (1999) 747-749
7. Gonzalez C.A., Sala N., and Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 100 (2002) 249-260
8. Wu M.S., Huang S.P., Chang Y.T., et al. Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 185 (2002) 106-109
9. Rad R., Dossumbekova A., Neu B., et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53 (2004) 1082-1089
10. Sutton P., Kolesnikow T., Danon S., Wilson J., and Lee A. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect Immun 68 (2000) 4802-4804
11. In: Higgins J.P.T., and Green S. (Eds). Cochrane handbook for systematic reviews of interventions 4.2.6. The Cochrane Library (2006), John Wiley & Sons, Ltd., Chichester, UK updated September 2006
12. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj 315 (1997) 629-634
13. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
14. Con S.A., Con-Wong R., Con-Chin G.R., et al. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica. Cancer Epidemiol Biomarkers Prev 16 (2007) 2631-2636
15. Leung W.K., Chan M.C., To K.F., et al. H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol 101 (2006) 714-720
16. Kato I., Canzian F., Franceschi S., et al. Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Control 17 (2006) 1183-1191
17. Bai X.L., Sun L.P., Liu J., Chen W., Zhang Y., and Yuan Y. [Correlation of Interleukin-10-1082G/A Single Nucleotide Polymorphism to the Risk of Gastric Cancer in North China: A Case-Control Study.]. Ai Zheng 27 (2008) 35-40
18. Deans C., Rose-Zerilli M., Wigmore S., et al. Host cytokine genotype is related to adverse prognosis and systemic inflammation in gastro-oesophageal cancer. Ann Surg Oncol 14 (2007) 329-339
19. Wu M.S., Wu C.Y., Chen C.J., Lin M.T., Shun C.T., and Lin J.T. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 104 (2003) 617-623
20. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201
21. Savage S.A., Abnet C.C., Haque K., et al. Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. Cancer Epidemiol Biomarkers Prev 13 (2004) 1547-1549
22. Lu W., Pan K., Zhang L., Lin D., Miao X., and You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis 26 (2005) 631-636
23. Zambon C.F., Basso D., Navaglia F., et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29 (2005) 141-152
24. Guo W., Wang N., Wang Y.M., et al. Interleukin-10-1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. World J Gastroenterol 11 (2005) 858-862
25. Lee J.Y., Kim H.Y., Kim K.H., et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 225 (2005) 207-214
26. Alpizar-Alpizar W., Perez-Perez G.I., Une C., Cuenca P., and Sierra R. Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med 5 (2005) 169-176
27. Kamangar F., Abnet C.C., Hutchinson A.A., et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17 (2006) 117-125
28. Morgan D.R., Dominguez R.L., Keku T.O., et al. Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol 4 (2006) 1103-1111
29. Garcia-Gonzalez M.A., Lanas A., Quintero E., et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 102 (2007) 1878-1892
30. Sugimoto M., Furuta T., Shirai N., et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 22 (2007) 1443-1449
31. Zhou Y., Li N., Zhuang W., et al. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer 121 (2007) 1481-1486
32. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
33. Machado J.C., Pharoah P., Sousa S., et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 (2001) 823-829
34. Loder N. Genetic variations can point the way to disease genes. Nature 401 (1999) 734
35. Schaid D.J., and Jacobsen S.J. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 149 (1999) 706-711
36. Deng H.W., Chen W.M., and Recker R.R. Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics 157 (2001) 885-897
37. Thomas D.C., and Witte J.S. Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol Biomarkers Prev 11 (2002) 505-512
38. Langsenlehner U., Krippl P., Renner W., et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 90 (2005) 113-115
39. Ioana Braicu E., Mustea A., Toliat M.R., et al. Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients. Gynecol Oncol 104 (2007) 680-685
40. Shih C.M., Lee Y.L., Chiou H.L., et al. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung cancer 50 (2005) 291-297
41. Faupel-Badger J.M., Kidd L.C., Albanes D., Virtamo J., Woodson K., and Tangrea J.A. Association of IL-10 polymorphisms with prostate cancer risk and grade of disease. Cancer Causes Control 19 (2008) 119-124
42. Nath S.K., Harley J.B., and Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 118 (2005) 225-234